Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details
Due to limited systemic treatment options, peritoneal carcinomatosis of gastric origin is still associated with a dismal outcome and is claimed a terminal disease. In the past, surgery had not been considered as a potential treatment option. However, there is emerging evidence that in selected patie...
Saved in:
| Main Authors: | Thomas Boerner, Pompiliu Piso |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
MDPI AG
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/ecb0e7185dfe447bb874fced6406f369 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Implementation of the enhanced
recovery after surgery protocol for patients with peritoneal
carcinomatosis undergoing cytoreductive surgery and
hyperthermic intraperitoneal chemoperfusion
by: Oleksandr Ivanovych Tkachenko, et al.
Published: (2021) -
The Role of CAR-T Cells in Peritoneal Carcinomatosis from Gastric Cancer: Rationale, Experimental Work, and Clinical Applications
by: Siyuan Qian, et al.
Published: (2021) -
Carcinomatosis peritoneal secundaria a carcinoma mucoepidermoide de glándula salival
by: Sánchez P.,Marcelo, et al.
Published: (2018) -
Imaging of Gastric Carcinomatosis
by: Raquel Saiz Martínez, et al.
Published: (2021) -
CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review
by: Panagiota Berta Panagiotopoulou, et al.
Published: (2021)